Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.

导出原文传递

翻译打印收藏纠错

作者： Mark J,Rutherford ^[1] ; Melina,Arnold ^[2] ; Aude,Bardot ^[1] ; Jacques,Ferlay ^[1] ; Prithwish,De ^[1] ; Hannah,Tervonen ^[3] ; Alana,Little ^[4] ; Oliver,Bucher ^[4] ; Nathalie,St Jacques ^[5] ; Anna,Gavin ^[6] ; Gerda,Engholm ^[7] ; Bjørn,Møller ^[8] ; Dianne L,O'Connell ^[9] ; Neil,Merrett ^[10] ; Donald Maxwell,Parkin ^[11] ; Freddie,Bray ^[1] ; Isabelle,Soerjomataram ^[12]

作者单位： International Agency for Research on Cancer, Lyon, France. ^[1] Biostatistics Research Group, University of Leicester, Leicester, UK. ^[2] Analytics and Informatics, Cancer Care Ontario, Toronto, Ontario, Canada. ^[3] Cancer Institute NSW, Alexandria, Australia. ^[4] Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada. ^[5] Nova Scotia Health Authority Cancer Care Program, Registry & Analytics, Halifax, Nova Scotia, Canada. ^[6] Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, Northern Ireland, UK. ^[7] Danish Cancer Society Research Centre, Cancer Surveillance and Pharmacoepidemiology, Copenhagen, Denmark. ^[8] Department of Registration, Cancer Registry of Norway, Oslo, Norway. ^[9] The Daffodil Centre, The University of Sydney (A Joint Venture with Cancer Council NSW), Camperdown, Australia. ^[10] School of Medicine, Western Sydney University, Campbelltown, Australia. ^[11] Nuffield Department of Population Health, University of Oxford, Oxford, UK. ^[12]

关键词 International Cancer Benchmarking Partnership hepatobiliary cancers incidence trends international variation net survival population-based